Cibus, Inc. CBUS
Set alert
At close · Nov 2
After hours · Nov 2, 4:00 PM ET
- YTD
- -28.74%
- 1 year
- -22.50%
- Open
- 1.37
- Prev close
- 1.29
- Mkt cap
- 94.77M
- Vol
- 76.67K
- Avg vol
- 115.58K
- EPS
- -1.62
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.22
- High
- 1.37
- Forward P/E
- -1.09
- Beta
- 1.79
- Short ratio
- 14.59
- Inst. own
- 33.74%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 4.14
- 200-d avg
- 9.75
- 1y target
- 18.13
News
-
1 month ago benzinga.com
Crystal Crop Protection And Cibus Announce Agreement To Develop Gene-Edited Traits In Brassica Juncea
Crystal Crop Protection Limited ("Crystal Crop"), an Indian crop solutions company, and Cibus, Inc. (NASDAQ:CBUS) a technology company that uses biology to produce sustainable ingredients and helps…
1 month ago globenewswire.com
Cibus and Crystal Crop Protection Team Up to Improve India's Mustard Crop
Collaboration pairs Cibus' platform for improving a plant's own genes with Crystal Crop's mustard varieties and its reach across India, with the goal of putting better-performing seed in growers'…
2 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Capricor Therapeutics (NASDAQ:CAPR) stock rose 94.8% to $8.2 during Friday's pre-market session. The company's market cap stands at $243.8 million. As per the news, the Q2 earnings report…
2 months ago seekingalpha.com
Cibus, Inc. (CBUS) Q2 2026 Earnings Call Transcript
Cibus, Inc. (CBUS) Q2 2026 Earnings Call Transcript
2 months ago zacks.com
Cibus (CBUS) Reports Q2 Loss, Misses Revenue Estimates
Cibus (CBUS) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to a loss of $0.61 per share a year ago.
2 months ago marketbeat.com
Cibus Q2 Earnings Call Highlights
Cibus NASDAQ: CBUS reported second-quarter 2026 revenue of $1.0 million, compared with $0.9 million a year earlier, as the agricultural biotechnology company advanced its Sustainable Ingredients…
-
2 months ago benzinga.com
Transcript: Cibus Q2 2026 Earnings Conference Call
On Thursday, Cibus (NASDAQ:CBUS) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga APIs. For…
2 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Akanda (NASDAQ:AKAN) stock rose 109.4% to $10.49 during Thursday's after-market session. The company's market cap stands at $2.9 million. Capricor Therapeutics (NASDAQ:CAPR) stock moved…
-
2 months ago benzinga.com
Cibus Q2 EPS $(0.29) Misses $(0.26) Estimate, Sales $994.000K Miss $1.704M Estimate
Cibus (NASDAQ:CBUS) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.26) by 11.54 percent. This is a 52.46 percent increase over losses of $(0.61) per…
2 months ago globenewswire.com
Cibus Reports Second Quarter Financial Results and Provides Business Update
Commercialization execution advances in Rice and Sustainable Ingredients United States and European Union now aligned on generally treating crops with no added foreign DNA as conventionally bred…
3 months ago globenewswire.com
Cibus to Report Second Quarter 2026 Financial Results on August 13, 2026 After the Market Close and Host Conference Call
SAN DIEGO, July 30, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a technology company that helps farmers grow more food with fewer inputs, today announced that the company will report second…
3 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers NextCure (NASDAQ:NXTC) stock increased by 201.4% to $6.57 during Tuesday's regular session. The market value of their outstanding shares is at $7.8 million. Shuttle Pharmaceuticals…
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers OSR Health (NASDAQ:OSRH) stock increased by 7.2% to $0.33 during Wednesday's after-market session. The company's market cap stands at $11.0 million. BioRestorative Therapies (NASDAQ:BRTX)…
4 months ago globenewswire.com
Europe Recognizes Nature-Based Plant Improvement, Opening a New Pathway for Cibus
Under new EU rules, crops improved without adding foreign DNA will be treated like conventionally bred crops, validating the approach Cibus has developed for 25 years Under new EU rules, crops…
4 months ago globenewswire.com
Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer to Accelerate Growth and Value Creation
SAN DIEGO, June 08, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed…
5 months ago seekingalpha.com
Cibus, Inc. (CBUS) Q1 2026 Earnings Call Transcript
Cibus, Inc. (CBUS) Q1 2026 Earnings Call Transcript
5 months ago zacks.com
Cibus (CBUS) Reports Q1 Loss, Beats Revenue Estimates
Cibus (CBUS) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to a loss of $0.74 per share a year ago.
5 months ago marketbeat.com
Cibus Q1 Earnings Call Highlights
Cibus NASDAQ: CBUS reported first-quarter 2026 results and said it is advancing toward commercialization across its rice and sustainable ingredients programs, while also reducing expenses and…
-
5 months ago benzinga.com
Cibus Q1 2026 Earnings Call: Complete Transcript
Cibus Q1 2026 Earnings Call: Complete Transcript
-
5 months ago benzinga.com
Cibus Q1 EPS $(0.33), Inline, Sales $1.681M Beat $1.616M Estimate
Cibus (NASDAQ:CBUS) reported quarterly losses of $(0.33) per share which met the analyst consensus estimate. This is a 55.41 percent increase over losses of $(0.74) per share from the same period…
5 months ago globenewswire.com
Cibus Reports First Quarter Financial Results and Provides Business Update
SAN DIEGO, May 14, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today…
6 months ago zacks.com
Cibus (CBUS) Upgraded to Buy: What Does It Mean for the Stock?
Cibus (CBUS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
6 months ago globenewswire.com
Cibus Announces Transfer of Gene-Edited Herbicide Tolerance Traits in Interoc Rice Seeds for Testing and Production
Represents achievement of strategic milestone for Cibus' anticipated first commercial offering in the South American market Represents achievement of strategic milestone for Cibus' anticipated first…
6 months ago globenewswire.com
Cibus to Report First Quarter 2026 Financial Results on May 14, 2026 After the Market Close and Host Conference Call
SAN DIEGO, April 30, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the…
6 months ago globenewswire.com
Cibus Announces the Election of Thomas Urban to Board of Directors
SAN DIEGO, April 15, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed…
6 months ago globenewswire.com
Cibus, Inc. Investigated by the Portnoy Law Firm
LOS ANGELES, April 08, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Cibus , Inc. , (“ Cibus " or the "Company") ( NASDAQ : CBUS ) investors that the firm has initiated an investigation into…
-
7 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
7 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
12 Health Care Stocks Moving In Thursday's Pre-Market Session
-
7 months ago benzinga.com
Cibus Prices Public Offering Of 6.98M Shares At $2.15 Each
Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced the pricing of an…
7 months ago globenewswire.com
Cibus, Inc. Announces Pricing of Public Offering of Class A Common Stock
SAN DIEGO, March 26, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed…
7 months ago benzinga.com
Why Navan Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket
Shares of Navan Inc (NASDAQ: NAVN) spiked in pre-market trading on better-than-expected Q4 results. Gainers include EEIQ, FCHL, OLPX, SLND, PGEN, EDHL, NFGC, NEXT, and VG. Losers include MGN, CBUS,…
-
7 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
-
7 months ago benzinga.com
Cibus Commencing Class Common Stock, Pre-Funded Warrants Offering; Terms Not Disclosed
Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that it intends to offer…
7 months ago globenewswire.com
Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock and Pre-Funded Warrants
SAN DIEGO, March 25, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed…
-
7 months ago benzinga.com
Jefferies Maintains Hold on Cibus, Raises Price Target to $3
Jefferies analyst Laurence Alexander maintains Cibus (NASDAQ:CBUS) with a Hold and raises the price target from $1.9 to $3.
-
7 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
7 months ago seekingalpha.com
Cibus, Inc. (CBUS) Q4 2025 Earnings Call Transcript
Cibus, Inc. (CBUS) Q4 2025 Earnings Call Transcript
-
7 months ago benzinga.com
Cibus Q4 Adj. EPS $(0.42) Beats $(0.43) Estimate, Sales $1.057M Miss $1.644M Estimate. Adj. EPS excludes asset impairment charge of $0.17.
Cibus (NASDAQ:CBUS) reported quarterly losses of $(0.42) per share which beat the analyst consensus estimate of $(0.43) by 2.33 percent. This is a 51.72 percent increase over losses of $(0.87) per…
-
7 months ago benzinga.com
Earnings Scheduled For March 17, 2026
Earnings Scheduled For March 17, 2026
-
11 months ago benzinga.com
Earnings Scheduled For November 13, 2025
Earnings Scheduled For November 13, 2025
1 year ago benzinga.com
Soybean Short Squeeze: Cooking Oil Stocks Pop After Trump Targets China
Soybean-related stocks exploded on Wednesday following President Donald Trump's latest comments in the ongoing trade war with China.
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
1 year ago benzinga.com
Why Veritone Shares Are Trading Higher By Over 48%; Here Are 20 Stocks Moving Premarket
Why Veritone Shares Are Trading Higher By Over 48%; Here Are 20 Stocks Moving Premarket
1 year ago benzinga.com
What's Driving Cibus Inc.'s Pre-Market Surge Amid Trump's China Trade Warning?
CBUS stock surged 23.81% in pre-market trading following Trump's trade escalation with China, causing gains in agricultural stocks.
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session
-
1 year ago benzinga.com
Earnings Scheduled For August 14, 2025
Earnings Scheduled For August 14, 2025
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
1 year ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
12 Health Care Stocks Moving In Thursday's Pre-Market Session